Adarx Pharmaceuticals, Inc.
Clinical trials sponsored by Adarx Pharmaceuticals, Inc., explained in plain language.
-
First human tests begin for new swelling disorder drug
Disease control OngoingThis early-stage study is testing a new drug called ADX-324 to see if it's safe for people. First, healthy volunteers receive different doses. Then, a small group of patients with hereditary angioedema—a rare condition causing sudden, severe swelling—will try it. The main goal is…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for PNH patients battling anemia
Disease control OngoingThis early-stage study is testing a new drug called ADX-038. First, it checks for safety in healthy volunteers. Then, it will be given to a small group of people with PNH who still have anemia despite being on their current standard medication. The main goal is to see if the drug…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New blood pressure drug begins human testing
Disease control OngoingThis early-stage study is testing a new medication called ADX-850 for people with high blood pressure. Researchers will check if the drug is safe and how it affects blood pressure in 28 participants. This is the first time this medication is being tested in humans, so the main go…
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC